{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:23:49Z","timestamp":1772936629560,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.aed.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:43:48Z","timestamp":1752623028000},"page":"162-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rare Occurrence of Distant Metastases in Prolactinoma: Insights From 2 Cases and Review of the Literature"],"prefix":"10.1016","volume":"12","author":[{"given":"Vidisha","family":"Master","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"Hann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Gallia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Calixto-Hope G.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshana","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aed.2025.07.002_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1507\/endocrj.EJ23-0007","article-title":"Aggressive pituitary tumors (PitNETs)","volume":"70","author":"Nishioka","year":"2023","journal-title":"Endocr J"},{"issue":"7","key":"10.1016\/j.aed.2025.07.002_bib2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgad098","article-title":"Aggressive pituitary tumors and pituitary carcinomas: from Pathology to treatment","volume":"108","author":"Burman","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.aed.2025.07.002_bib3","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2004.16.4.8","article-title":"Pituitary carcinoma: a review of the literature","volume":"16","author":"Ragel","year":"2004","journal-title":"Neurosurg Focus"},{"issue":"2","key":"10.1016\/j.aed.2025.07.002_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11102-017-0857-z","article-title":"Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)","volume":"21","author":"Lenders","year":"2018","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.aed.2025.07.002_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.1.02268","article-title":"Malignant prolactinoma: case report and review of the literature","volume":"155","author":"Kars","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.aed.2025.07.002_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jocn.2002.11.002","article-title":"Treatments of multi-invasive giant prolactinoma","volume":"11","author":"Yang","year":"2004","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.aed.2025.07.002_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ecl.2020.06.002","article-title":"Advances in the imaging of pituitary tumors","volume":"49","author":"MacFarlane","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.aed.2025.07.002_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.semnuclmed.2023.02.005","article-title":"Molecular imaging of pituitary tumors","volume":"53","author":"Gillett","year":"2023","journal-title":"Semin Nucl Med"},{"issue":"19","key":"10.1016\/j.aed.2025.07.002_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033726","article-title":"Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET\/CT in neuroendocrine tumors: a retrospective study","volume":"102","author":"Hu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aed.2025.07.002_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2019.08.008","article-title":"The pituitary in nuclear medicine imaging","volume":"68","author":"Iglesias","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.aed.2025.07.002_bib11","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1210\/jcem.82.9.4217","article-title":"Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression","volume":"82","author":"Hurel","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aed.2025.07.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101713","article-title":"Temozolomide in aggressive pituitary tumours and pituitary carcinomas","volume":"36","author":"McCormack","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2025.07.002_bib13","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.aed.2025.07.002_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11102-020-01040-4","article-title":"Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature","volume":"23","author":"Lizzul","year":"2020","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.aed.2025.07.002_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11102-021-01192-x","article-title":"Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay","volume":"25","author":"Ishida","year":"2022","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.aed.2025.07.002_bib16","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1210\/clinem\/dgaa805","article-title":"EGFR\/ErbB2-Targeting lapatinib therapy for aggressive prolactinomas","volume":"106","author":"Cooper","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.aed.2025.07.002_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/jcm8081107","article-title":"Emerging and novel treatments for pituitary tumors","volume":"8","author":"Ilie","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.aed.2025.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf178","article-title":"Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumors","author":"Lin","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.aed.2025.07.002_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11102-023-01340-5","article-title":"The treatment of aggressive prolactinomas with everolimus","volume":"26","author":"Lin","year":"2023","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.aed.2025.07.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101712","article-title":"Immunotherapy in pituitary carcinomas and aggressive pituitary tumors","volume":"36","author":"Raverot","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305091572500058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305091572500058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:27:13Z","timestamp":1758626833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S305091572500058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S305091572500058X"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.07.002","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare Occurrence of Distant Metastases in Prolactinoma: Insights From 2 Cases and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinologists. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}